BWX Technologies Reports Second Quarter 2021 Results and Continues Progress On Future Growth MilestonesBusiness Wire • 08/02/21
BWXT Medical Enters into a New Long-Term Agreement with Boston Scientific for the Manufacture of TheraSphere™ Y-90 Glass MicrospheresBusiness Wire • 05/10/21
BWX Technologies, Inc. (BWXT) CEO Rex Geveden on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/04/21
BWX Technologies Reports First Quarter 2021 Results and Commences New Multi-Year Guidance FrameworkBusiness Wire • 05/03/21
BWX Technologies (BWXT) Expected to Beat Earnings Estimates: Should You Buy?Zacks Investment Research • 04/26/21
BWXT Announces $2.2 Billion in Contracts for Naval Nuclear Reactor Components and FuelBusiness Wire • 04/20/21
BWX Technologies to Webcast Discussion of its First Quarter 2021 Results on Tuesday, May 4Business Wire • 04/15/21
BWXT Awarded $690 Million Extension for Environmental Management Work at PortsmouthBusiness Wire • 04/06/21
BWXT Awarded $35 Million in Uranium Processing and Research Reactor Fuel ContractsBusiness Wire • 03/11/21
BWXT and GMS Form Joint Venture in Nuclear Medicine Manufacturing and Distribution in the Asia-Pacific RegionBusiness Wire • 03/08/21
BWXT Subsidiary Awarded $57.5 Million Contract to Prepare for Uranium Conversion and Purification ServicesBusiness Wire • 03/01/21
BWXT to Present at J.P. Morgan Global High Yield & Leveraged Finance ConferenceBusiness Wire • 02/25/21